United Drug pre-tax profits climb 15%

United Drug has announced pre-tax profits up 15% to €22.34m for the half year ended 31 March 2005.

Group turnover in the period grew by 3% to €634m.

The company said each of their four divisions – Pharma Wholesale, Contract Distribution Outsourcing, Medical & Scientific and Contract Sales Outsourcing – performed well in the period.

"Given the strong performance in the first half of this year, I am confident that United Drug will report another very successful year," said chairman Martin Rafferty.